Starting new treatment for Prostate cancer?
Is PSA rising again after Hormone Treatment?
Do you or someone you care about have Prostate Cancer? If so, please consider taking part in the TRUMPET Registry Study
What is the TRUMPET Registry Study?
It is an observational Study of patients with Castration Registrant Prostate Cancer (CPRC) in the United States. The primary objectives are to describe patterns of care, disease assessment methods, treatment decisions, physician referrals and CRPC patient characteristics associated with these.
Who can join the TRUMPET Registry Study?
Men whose Prostate Cancer fits the following may be able to join:
• Has progressed despite treatment with hormonal therapy or with Castration Resistant Prostate Cancer
• Cancer remains in the prostate or spreads beyond
• Initiates the first active course of anti-cancer treatment such as anti-androgens, androgen synthesis inhibitors, chemotherapy, immunotherapy or radionuclide therapy. May be enrolled within 45 days from the time of treatment initiation.
Please call Tower Research at 310-854-9898 Ext: 178 or 168